CN1393443A - Process for preparing dihydromyricetin from porcelain ampelopsis - Google Patents

Process for preparing dihydromyricetin from porcelain ampelopsis Download PDF

Info

Publication number
CN1393443A
CN1393443A CN 01114564 CN01114564A CN1393443A CN 1393443 A CN1393443 A CN 1393443A CN 01114564 CN01114564 CN 01114564 CN 01114564 A CN01114564 A CN 01114564A CN 1393443 A CN1393443 A CN 1393443A
Authority
CN
China
Prior art keywords
dihydromyricetin
purity
thick
adsorptive resins
macroporous adsorptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 01114564
Other languages
Chinese (zh)
Inventor
张友胜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Baidi Bio-technology Co., Ltd.
Original Assignee
张友胜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 张友胜 filed Critical 张友胜
Priority to CN 01114564 priority Critical patent/CN1393443A/en
Publication of CN1393443A publication Critical patent/CN1393443A/en
Pending legal-status Critical Current

Links

Abstract

A process for prparing dihydromyricetin from bigdentate ampelopsis includes such steps as providing the dried stems and leaves of bigdentate ampelopsis, immersion extracting in water or alcohol at 50-100 deg.c for 0.5-3 hr, vacuum-filtering, concentrating the filtrate to obtain coarse dihydromyricatin, drying, purifying and refining. The resultant dihydromyricatin is a medicine for arrhythmia, myocardial ischemia, hypertension, obesity, etc.

Description

Produce the method for dihydromyricetin with porcelain ampelopsis
The present invention relates to a kind of method of producing dihydromyricetin with porcelain ampelopsis.
Showing tooth snake plant Ampelopsis grossedentata (Hand.-Mazz.) W.T.Wang. is a kind of wild vine of Vitaceae Ampelopsis.Mainly be distributed in provinces and regions such as China Guangdong, Guangxi, Yunnan, Guizhou, Hunan, Hubei, Jiangxi, Fujian.Mutation A.cantoniesis (H.et.A.) Pl.var.grossedentata Hand-Mazz for ampelopsis cantoniensis.The provinces and regions Zhuang such as China Guangxi, Hunan and the people of the Yao nationality its young young stem and leaf commonly used is gone into tea, and make tea summer do not turn sour a few days, has " title of refreshing tea ", also claims " vine tea ", " white tea ", " Maoyanmei tea ".Complete stool is medicinal, flavor is sweet, light, cool in nature, have effects such as clearing heat and detoxicating, wind-damp dispelling, strengthening the bones and muscles.Among the people its young stem and leaf is made health tea, be used for the treatment of diseases such as heating, swelling and pain in the throat, icterohepatitis, blister furuncle, the use history in existing hundreds of years.Ampelopsis grossedentata mainly is distributed in 400-1300 rice above sea level, concentrates or scattered wild reserves are big in the mixing in the woods of hillside, distribute and growth rhythm more clear, make wild change man plant the expansion stock number easily in addition.Be the wild plant resource that can directly utilize.
Studies confirm that, mainly contain dihydromyricetin isoreactivity composition in the porcelain ampelopsis body, wherein contain dihydromyricetin in the young leaflet tablet that pluck March to September and reach 35% (dry weight).
Dihydromyricetin (dihydromyricetin) has another name called Ampelopstin (ampelopsin), holds back element (ampelopsin), dihydromyricetin flavones (dihydromyricetin), ampelopsin (ampelopsin) in vain.Traditionally, people are called for short dibydro myricetrin (dihydromyricetin), and it comprises multiple isomers, and chemical structural formula is as follows:
In recent years, pharmacological evaluation both domestic and external shows: it has obvious antagonism norepinephrine and high K +Due to rabbit thoracic aorta bar contractile response and calcium antagonism, and toxicity is low, can be used as anti-arrhythmia, resist myocardial ischemia, antihypertensive newtype drug; Tool significantly eliminates the phlegm, anti-inflammatory, cough-relieving, lipopenicillinase, liver protection function; Tool is significantly removed the effect of alcoholism; The formation of tool obvious suppression extracorporeal platelet aggregation and thrombus in vivo, blood fat reducing and glucose level, SOD activity improving is expected to be developed as one, two national kind new medicines.
In the plant of having found that contains this composition, this component content is very low, let alone industrialization extraction, purified problem.So this composition fails to be used widely always.
Purpose one of the present invention is to extract dihydromyricetin from porcelain ampelopsis, the 2nd, with the thick dihydromyricetin that extracts purify, refining be dihydromyricetin 90% or more, a kind of method with porcelain ampelopsis production dihydromyricetin promptly is provided
The objective of the invention is to realize with the following methods.
Get the dry cauline leaf of porcelain ampelopsis, water or ethanol are pressed solid-liquid ratio 1: (1-20) under 50-100 ℃ temperature, lixiviate 0.5-3 hour, filtration under diminished pressure, concentrated filtrate, the crude extract of dihydromyricetin, the dry raw extract, the dry thing of thick dihydromyricetin, again it is purified and makes with extra care.
The purification of thick dihydromyricetin, refining: two kinds of methods are arranged:
A: the hot water that is soluble in that utilizes dihydromyricetin, can be dissolved in the characteristics of cold water again, put the crude extract of dihydromyricetin cold, or with (70-100 ℃) dissolving in hot water of thick dihydromyricetin, it is cold that lysate is put, just separate out a large amount of dihydromyricetin crystal in the solution, filtration under diminished pressure, filtrate reenter extractor, filter residue leaves standstill, filters with hot water dissolving and cooling again, continue preceding step,, can add small amount of activated with among the hot water dissolving, purification speed is accelerated in the decolouring impurity elimination.Through 4-10 time the circulation, can be with the rough monomer that is purified to purity>90% of thick dihydromyricetin, its technological process of production as shown in Figure 1, that is:
Fig. 1 is a kind of technological process of production figure of the present invention
Produce the gained filter residue by technological process shown in Figure 1 and use the hot water dissolving, heavy Multiple process flow steps shown in Figure 1.
With cocycle the 7-8 time the dihydromyricetin list more than>90% Body, the 9-10 time dihydromyricetin monomer more than>95%.
B method: the dihydro that utilizes uniform temperature (50 ℃ more than-100 ℃) When the myricetin crude extract passes through macroporous absorbent resin, the macroporous absorption tree Fat mainly adsorb the characteristics of impurity and make with extra care, the purification dihydromyricetin.
The water-soluble liquid of dihydromyricetin crude extract or dry thing, insulation Or heating makes solution 50 ℃ of temperature more than-100 ℃, and solution insulation is logical Cross first large pore resin absorption column, speed 2-3 column volume/hour, mistake Filtrate is continued under keeping warm mode by second, the 3rd macroporous absorption Resin column. The number of times that solution is crossed post requires the purity of product to decide on manufacturer, Crossing for the first time behind the large pore resin absorption column product purity can be more than 70%, Cross for the second time that the large pore resin absorption column product can reach more than 80%, cross the 3rd Inferior large pore resin absorption column product can reach more than 90%. Such as need high-purity more Product (more than 95%), then can make for the third time large pore resin absorption column The post liquid cooling of crossing but leave standstill, filtration under diminished pressure, dry filter residue namely get 95% with The dihydromyricetin of upper purity.
The technical problem that the invention solves: the one, in the minimum feelings of cost Extract to greatest extent dihydromyricetin in the aobvious tooth mattae under the condition; The 2nd, under simple scenario, purify, refining dihydromyricetin.
Below be non-limiting examples of the present invention:
Embodiment 1: get the dry cauline leaf of porcelain ampelopsis, water is pressed solid-liquid ratio 1: 10 under 100 ℃ temperature, lixiviate 1 hour, filtration under diminished pressure, concentrated filtrate, the crude extract of dihydromyricetin, the dry raw extract, the dry thing of the thick dihydromyricetin of purity about 40%, again it is purified and makes with extra care.
The purification of thick dihydromyricetin, refining: the hot water that is soluble in that utilizes dihydromyricetin, be insoluble in the characteristics of cold water, put the crude extract of dihydromyricetin cold, or with (80 ℃) dissolving in hot water of the dry thing of thick dihydromyricetin, it is cold that lysate is put, just separate out a large amount of dihydromyricetin crystal in the solution, filtration under diminished pressure, filtrate reenter extractor, filter residue leaves standstill, filters with hot water dissolving and cooling again, continue preceding step,, can add small amount of activated with among the hot water dissolving, purification speed is accelerated in the decolouring impurity elimination.Through 8 circulations, thick dihydromyricetin can be purified to the monomer of purity>90%.
Embodiment 2: get the dry cauline leaf of porcelain ampelopsis, water is pressed solid-liquid ratio 1: 10 under 100 ℃ temperature, lixiviate 1 hour, filtration under diminished pressure, concentrated filtrate, the crude extract of the dihydromyricetin of purity about 40%, the dry raw extract, the dry thing of thick dihydromyricetin, again it is purified and makes with extra care.
The purification of thick dihydromyricetin, refining: the dihydromyricetin crude extract that utilizes certain temperature (50-100 ℃) is during by NKA-9 (department of chemistry of Nankai University product) macroporous adsorbent resin, macroporous adsorbent resin mainly adsorb the characteristics of impurity and make with extra care, the purification dihydromyricetin.
The water-soluble liquid of dihydromyricetin crude extract or dry thing, insulation or heating make solution in the insulation of the temperature more than 50-100 ℃ → solution by first NKA-9 (department of chemistry of Nankai University product) macroporous adsorptive resins, speed 2 column volumes/hour → filtered liquid continues under keeping warm mode by second, the 3rd NKA-9 macroporous adsorptive resins.The number of times that solution is crossed post requires the purity of product to decide on manufacturer, product purity can be more than 70% after crossing the NKA-9 macroporous adsorptive resins first time, crossing for the second time behind the NKA-9 macroporous adsorptive resins product purity can be more than 80%, can reach more than 90% after macroporous adsorptive resins product for the third time.As the more highly purified product of need (more than 95%), the post liquid cooling of crossing of macroporous adsorptive resins was for the third time but left standstill, filtration under diminished pressure, dry filter residue promptly gets the dihydromyricetin of 95% above purity.

Claims (3)

1, a kind of method of producing dihydromyricetin with porcelain ampelopsis, it is characterized in that getting the dry cauline leaf of porcelain ampelopsis, water or ethanol are pressed solid-liquid ratio 1: (1-20) under 50-100 ℃ temperature, lixiviate 0.5-3 hour, filtration under diminished pressure, concentrated filtrate, get the crude extract of dihydromyricetin, the dry raw extract, the dry thing of the thick dihydromyricetin of purity about 40%, again it is purified and makes with extra care.
2, according to the described method of producing dihydromyricetin with porcelain ampelopsis of claim 1, it is characterized in that the purification of thick dihydromyricetin, refining is the hot water that is soluble in that utilizes dihydromyricetin, be insoluble in the characteristics of cold water, put the crude extract of dihydromyricetin cold, or with (70-100 ℃) dissolving in hot water of thick dihydromyricetin, it is cold that lysate is put, just separate out a large amount of dihydromyricetin crystal in the solution, filtration under diminished pressure, filtrate reenters extractor, filter residue leaves standstill with hot water dissolving and cooling again, filter, continue preceding step, in using the hot water dissolving, can add small amount of activated, purification speed is accelerated in the decolouring impurity elimination.Through 4-10 circulation, can be with the rough monomer that is purified to purity>90% of thick dihydromyricetin.
3, according to the described method of producing dihydromyricetin with porcelain ampelopsis of claim 1, it is characterized in that the purification of thick dihydromyricetin, refining is the dihydromyricetin crude extract during by macroporous adsorbent resin that utilizes certain temperature (more than 50-100 ℃), macroporous adsorbent resin mainly adsorbs the characteristics of impurity and makes with extra care, the purification dihydromyricetin, the water-soluble liquid of dihydromyricetin crude extract or dry thing, insulation or heating make solution in the insulation of the temperature more than 50-100 ℃ → solution by first macroporous adsorptive resins, speed 2-3 column volume/hour → filtered liquid continues under keeping warm mode by second, the 3rd macroporous adsorptive resins.The number of times that solution is crossed post requires the purity of product to decide on manufacturer, product purity can be more than 70% after crossing the macroporous adsorptive resins first time, crossing for the second time behind the macroporous adsorptive resins product purity can be more than 80%, can reach more than 90% after macroporous adsorptive resins product purity for the third time.As the more highly purified product of need (more than 95%), the post liquid cooling of crossing of macroporous adsorptive resins was for the third time but left standstill, filtration under diminished pressure, dry filter residue promptly gets the dihydromyricetin of 95% above purity.
CN 01114564 2001-06-29 2001-06-29 Process for preparing dihydromyricetin from porcelain ampelopsis Pending CN1393443A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01114564 CN1393443A (en) 2001-06-29 2001-06-29 Process for preparing dihydromyricetin from porcelain ampelopsis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01114564 CN1393443A (en) 2001-06-29 2001-06-29 Process for preparing dihydromyricetin from porcelain ampelopsis

Publications (1)

Publication Number Publication Date
CN1393443A true CN1393443A (en) 2003-01-29

Family

ID=4661201

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01114564 Pending CN1393443A (en) 2001-06-29 2001-06-29 Process for preparing dihydromyricetin from porcelain ampelopsis

Country Status (1)

Country Link
CN (1) CN1393443A (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2241491A1 (en) * 2004-04-07 2005-10-16 Provital, S.A. Composition for controlling fat content and differentiation of adipocytes, useful for treating cellulite, comprising dihydroflavonol, e.g. dihydromyricetin
WO2005117922A1 (en) * 2004-06-04 2005-12-15 Bright Future Pharmaceutical Laboratories Limited Usage of the plant of genus ampelopsis and extracts thereof for manufacture of medicament and functional food
CN100345539C (en) * 2003-05-30 2007-10-31 任启生 Composition containing dihydro myricitrin and myricitrin
CN100387588C (en) * 2005-05-30 2008-05-14 广州汉方现代中药研究开发有限公司 Method for distilling myricetin from plant
CN100389766C (en) * 2003-10-30 2008-05-28 湖南省中医药研究院 Pharmaceutical use of dihydro myricetin
CN101824018A (en) * 2010-04-30 2010-09-08 韩山师范学院 Method for purifying dihydromyricetin
CN102093330A (en) * 2010-12-30 2011-06-15 张家界茅岩莓有限公司 Method for semi-synthesizing (+)- epigallocatechin by utilizing dihydromyricetin
CN102106931A (en) * 2010-12-30 2011-06-29 张家界茅岩莓有限公司 Method for producing diverse extracts of berry tea
CN102772586A (en) * 2011-05-13 2012-11-14 贵州省生物研究所 Preparation with hangover alleviating and liver protection functions and preparation method thereof
CN102772587A (en) * 2011-05-13 2012-11-14 贵州省生物研究所 Preparation with cough relieving and phlegm reduction functions and preparation method thereof
CN102875510A (en) * 2012-10-22 2013-01-16 长沙盛凯生物科技有限公司 Process method for extracting high-content dihydromyricetin from ampelopsis grossedentata
CN103923051A (en) * 2014-04-30 2014-07-16 来凤凤雅藤茶生物有限公司 Industrial extracting method for ampelopsin
CN104522639A (en) * 2014-12-10 2015-04-22 甘肃陇神戎发药业股份有限公司 Anti-intoxication, alcohol-expelling and liver-protection preparation and preparation process thereof
CN105153091A (en) * 2015-08-25 2015-12-16 华中科技大学同济医学院附属同济医院 Method for increasing yield of dihydromyricetin in ampelopsis grossedentata
CN106901360A (en) * 2017-02-04 2017-06-30 大连海洋大学 Ampelopsis grossdentata dry powder and purposes
CN108047184A (en) * 2018-01-25 2018-05-18 张家界久瑞生物科技有限公司 A kind of method that dihydromyricetin is extracted from ampelopsis grossdentata
CN109288760A (en) * 2018-11-27 2019-02-01 广东中测食品化妆品安全评价中心有限公司 A kind of plant essence face cream and preparation method thereof

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100345539C (en) * 2003-05-30 2007-10-31 任启生 Composition containing dihydro myricitrin and myricitrin
CN100389766C (en) * 2003-10-30 2008-05-28 湖南省中医药研究院 Pharmaceutical use of dihydro myricetin
ES2241491B1 (en) * 2004-04-07 2006-12-01 Provital, S.A. COSMETIC AND / OR PHARMACEUTICAL COMPOSITION, REGULATOR OF FAT LEVELS IN ADIPOCYTES AND / OR REGULATOR OF ADIPOCITARY DIFFERENTIATION.
ES2241491A1 (en) * 2004-04-07 2005-10-16 Provital, S.A. Composition for controlling fat content and differentiation of adipocytes, useful for treating cellulite, comprising dihydroflavonol, e.g. dihydromyricetin
WO2005117922A1 (en) * 2004-06-04 2005-12-15 Bright Future Pharmaceutical Laboratories Limited Usage of the plant of genus ampelopsis and extracts thereof for manufacture of medicament and functional food
CN100387588C (en) * 2005-05-30 2008-05-14 广州汉方现代中药研究开发有限公司 Method for distilling myricetin from plant
CN101824018A (en) * 2010-04-30 2010-09-08 韩山师范学院 Method for purifying dihydromyricetin
CN102106931B (en) * 2010-12-30 2013-03-20 张家界茅岩莓有限公司 Method for producing diverse extracts of berry tea
CN102093330A (en) * 2010-12-30 2011-06-15 张家界茅岩莓有限公司 Method for semi-synthesizing (+)- epigallocatechin by utilizing dihydromyricetin
CN102106931A (en) * 2010-12-30 2011-06-29 张家界茅岩莓有限公司 Method for producing diverse extracts of berry tea
CN102093330B (en) * 2010-12-30 2013-03-20 张家界茅岩莓有限公司 Method for semi-synthesizing (+)- epigallocatechin by utilizing dihydromyricetin
CN102772587A (en) * 2011-05-13 2012-11-14 贵州省生物研究所 Preparation with cough relieving and phlegm reduction functions and preparation method thereof
CN102772586A (en) * 2011-05-13 2012-11-14 贵州省生物研究所 Preparation with hangover alleviating and liver protection functions and preparation method thereof
CN102875510A (en) * 2012-10-22 2013-01-16 长沙盛凯生物科技有限公司 Process method for extracting high-content dihydromyricetin from ampelopsis grossedentata
CN103923051A (en) * 2014-04-30 2014-07-16 来凤凤雅藤茶生物有限公司 Industrial extracting method for ampelopsin
CN104522639A (en) * 2014-12-10 2015-04-22 甘肃陇神戎发药业股份有限公司 Anti-intoxication, alcohol-expelling and liver-protection preparation and preparation process thereof
CN105153091A (en) * 2015-08-25 2015-12-16 华中科技大学同济医学院附属同济医院 Method for increasing yield of dihydromyricetin in ampelopsis grossedentata
CN105153091B (en) * 2015-08-25 2018-06-12 华中科技大学同济医学院附属同济医院 The method for improving dihydromyricetin yield in ampelopsis grossdentata
CN106901360A (en) * 2017-02-04 2017-06-30 大连海洋大学 Ampelopsis grossdentata dry powder and purposes
CN108047184A (en) * 2018-01-25 2018-05-18 张家界久瑞生物科技有限公司 A kind of method that dihydromyricetin is extracted from ampelopsis grossdentata
CN109288760A (en) * 2018-11-27 2019-02-01 广东中测食品化妆品安全评价中心有限公司 A kind of plant essence face cream and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1393443A (en) Process for preparing dihydromyricetin from porcelain ampelopsis
CN104621296B (en) It is a kind of that there is regulation blood fat, blood glucose, the Chinese traditional medicine composition tea beverage of blood pressure function
CN101053589B (en) Method for extracting active constituent from Tibetan capillary
CN101095724B (en) Technics for extracting lotus leaf flavone
CN101717418A (en) Technology for separating stevioside in one step with simulated moving bed
CN101747446B (en) Method for extracting anti-fatigue acidic ginseng polysaccharide
CN103735633B (en) A kind of preparation method of instant gardenia powder
CN104258193B (en) A kind of pharmaceutical composition for treating neurasthenia and prevention senile dementia
CN100439319C (en) Method for preparing salviol acid A
CN101709094A (en) Method for separating sweet tea polysaccharide by ultrafiltration membranes
CN102477104A (en) Method for separating and purifying polysaccharide from Hovenia acerba
CN1810798A (en) Process of extracting dihydromyricitrin from vine tea
CN101696381B (en) Novel process for preparing highland barley flavone extract and application thereof in health wine
CN107619427A (en) A kind of method of the extraction purification rhizoma paridis saponin I from Paris polyphylla
CN102648965A (en) Industrialization preparation method of lophatherum gracile general flavone
CN1543860A (en) Method for extracting bamboo leaf flavonoid and foodstuff and drug containing the same
KR100901379B1 (en) Method for separation and purification of corosolic acid from corosolic acid-containing materials
CN105541768A (en) Lithospermic acid B extraction method
CN101555447A (en) Carthamin wine and preparation method thereof
CN110054704A (en) The method that macroreticular resin purification bean jelly grass polysaccharide is combined using ammonium sulfate and CTAB precipitating
CN108440293A (en) A method of preparing high-purity chlorogenic acid by raw material of woodbine
CN102771850A (en) Method for preparing cooling drink by use of chrysanthemum straw
CN110548053A (en) a method for preparing fructus Hippophae extract rich in total flavonoids and natural vitamin C
CN102429965A (en) Method for preparing active ingredients in tree peony bark
CN103040951A (en) Method for extracting buckwheat flavonoids

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: GUANGZHOU ABADIE PHARMACEUTICAL BIOLOGY LTD.

Free format text: FORMER OWNER: ZHANG YOUSHENG

Effective date: 20030509

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20030509

Address after: Guangzhou Wanbao Industrial Park 511495 Panyu District Village

Applicant after: Guangzhou Baidi Bio-technology Co., Ltd.

Address before: 410128 Hunan province Changsha city Mapoling Hunan Agricultural University Training Center

Applicant before: Zhang Yousheng

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication